116 related articles for article (PubMed ID: 1791769)
1. Long-term treatment of atrophic vaginitis with low-dose oestradiol vaginal tablets.
Mettler L; Olsen PG
Maturitas; 1991 Dec; 14(1):23-31. PubMed ID: 1791769
[TBL] [Abstract][Full Text] [Related]
2. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
Rioux JE; Devlin C; Gelfand MM; Steinberg WM; Hepburn DS
Menopause; 2000; 7(3):156-61. PubMed ID: 10810960
[TBL] [Abstract][Full Text] [Related]
3. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
[TBL] [Abstract][Full Text] [Related]
4. Vaginal administration of low-dose oestradiol--effects on the endometrium and vaginal cytology.
Mattsson LA; Cullberg G; Eriksson O; Knutsson F
Maturitas; 1989 Sep; 11(3):217-22. PubMed ID: 2593865
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
[TBL] [Abstract][Full Text] [Related]
6. Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study.
Eriksen PS; Rasmussen H
Eur J Obstet Gynecol Reprod Biol; 1992 Apr; 44(2):137-44. PubMed ID: 1587379
[TBL] [Abstract][Full Text] [Related]
7. 17β-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
Rioux JE; Devlin MC; Gelfand MM; Steinberg WM; Hepburn DS
Menopause; 2018 Nov; 25(11):1208-1213. PubMed ID: 30358715
[TBL] [Abstract][Full Text] [Related]
8. [Safety of promestriene capsule used in postmenopausal atrophic vaginitis].
Sun AJ; Lin SQ; Jing LH; Wang ZY; Ye JL; Zhang Y
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):593-6. PubMed ID: 20003787
[TBL] [Abstract][Full Text] [Related]
9. Vaginal administration of low-dose conjugated estrogens: systemic absorption and effects on the endometrium.
Handa VL; Bachus KE; Johnston WW; Robboy SJ; Hammond CB
Obstet Gynecol; 1994 Aug; 84(2):215-8. PubMed ID: 8041532
[TBL] [Abstract][Full Text] [Related]
10. Local estrogen replacement therapy in postmenopausal atrophic vaginitis: efficacy and safety of low dose 17beta-estradiol vaginal tablets.
Mainini G; Scaffa C; Rotondi M; Messalli EM; Quirino L; Ragucci A
Clin Exp Obstet Gynecol; 2005; 32(2):111-3. PubMed ID: 16108394
[TBL] [Abstract][Full Text] [Related]
11. Action of 25 microg 17beta-oestradiol vaginal tablets in the treatment of vaginal atrophy in Greek postmenopausal women; clinical study.
Akrivis Ch; Varras M; Thodos A; Hadjopoulos G; Bellou A; Antoniou N
Clin Exp Obstet Gynecol; 2003; 30(4):229-34. PubMed ID: 14664420
[TBL] [Abstract][Full Text] [Related]
12. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
Ekin M; Yaşar L; Savan K; Temur M; Uhri M; Gencer I; Kıvanç E
Arch Gynecol Obstet; 2011 Mar; 283(3):539-43. PubMed ID: 20135132
[TBL] [Abstract][Full Text] [Related]
13. Local oestrogen for vaginal atrophy in postmenopausal women.
Suckling J; Lethaby A; Kennedy R
Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of low-dose regimens of conjugated estrogens cream administered vaginally.
Bachmann G; Bouchard C; Hoppe D; Ranganath R; Altomare C; Vieweg A; Graepel J; Helzner E
Menopause; 2009; 16(4):719-27. PubMed ID: 19436223
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
[TBL] [Abstract][Full Text] [Related]
16. Endometrial safety of ultra-low-dose Vagifem 10 microg in postmenopausal women with vaginal atrophy.
Ulrich LS; Naessen T; Elia D; Goldstein JA; Eugster-Hausmann M;
Climacteric; 2010 Jun; 13(3):228-37. PubMed ID: 20423243
[TBL] [Abstract][Full Text] [Related]
17. Management of post-menopausal vaginal atrophy and atrophic vaginitis.
Castelo-Branco C; Cancelo MJ; Villero J; Nohales F; Juliá MD
Maturitas; 2005 Nov; 52 Suppl 1():S46-52. PubMed ID: 16139449
[TBL] [Abstract][Full Text] [Related]
18. Oestradiol-releasing vaginal ring for treatment of postmenopausal urogenital atrophy.
Smith P; Heimer G; Lindskog M; Ulmsten U
Maturitas; 1993 Mar; 16(2):145-54. PubMed ID: 8483427
[TBL] [Abstract][Full Text] [Related]
19. Comparison of usefulness of estradiol vaginal tablets and estriol vagitories for treatment of vaginal atrophy.
Dugal R; Hesla K; Sørdal T; Aase KH; Lilleeidet O; Wickstrøm E
Acta Obstet Gynecol Scand; 2000 Apr; 79(4):293-7. PubMed ID: 10746845
[TBL] [Abstract][Full Text] [Related]
20. Low-dose oestradiol in the treatment of urogenital oestrogen deficiency--a pharmacokinetic and pharmacodynamic study.
Nilsson K; Heimer G
Maturitas; 1992 Oct; 15(2):121-7. PubMed ID: 1470044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
